Cabaletta Bio Valuation

CABA Stock  USD 12.96  0.36  2.70%   
At this time, the firm appears to be fairly valued. Cabaletta Bio shows a prevailing Real Value of $13.23 per share. The current price of the firm is $12.96. Our model approximates the value of Cabaletta Bio from analyzing the firm fundamentals such as current valuation of 406.35 M, and Return On Equity of -0.4 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Cabaletta Bio's valuation include:
Price Book
3.4813
Enterprise Value
406.3 M
Enterprise Value Ebitda
(8.00)
Fairly Valued
Today
12.96
Please note that Cabaletta Bio's price fluctuation is somewhat reliable at this time. Calculation of the real value of Cabaletta Bio is based on 3 months time horizon. Increasing Cabaletta Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cabaletta Bio is useful when determining the fair value of the Cabaletta stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cabaletta Bio. Since Cabaletta Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cabaletta Stock. However, Cabaletta Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  12.96 Real  13.23 Target  25.29 Hype  13.32 Naive  10.77
The real value of Cabaletta Stock, also known as its intrinsic value, is the underlying worth of Cabaletta Bio Company, which is reflected in its stock price. It is based on Cabaletta Bio's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Cabaletta Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cabaletta Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
13.23
Real Value
17.13
Upside
Estimating the potential upside or downside of Cabaletta Bio helps investors to forecast how Cabaletta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cabaletta Bio more accurately as focusing exclusively on Cabaletta Bio's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.57-0.47-0.31
Details
Hype
Prediction
LowEstimatedHigh
9.4213.3217.22
Details
Naive
Forecast
LowNext ValueHigh
6.8710.7714.66
Details
11 Analysts
Consensus
LowTarget PriceHigh
23.0125.2928.07
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cabaletta Bio's intrinsic value based on its ongoing forecasts of Cabaletta Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cabaletta Bio's closest peers. When choosing an evaluation method for Cabaletta Bio, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Cabaletta Bio Investments

(21.33 Million)

Cabaletta Valuation Trend

Knowing Cabaletta Bio's actual value is paramount for traders to make sound investment determinations. Cabaletta Bio's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Cabaletta Bio's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Cabaletta Bio's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Cabaletta Market Cap

Cabaletta Bio is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 19.07 Billion. Cabaletta Bio holds roughly 642.68 Million in market capitalization claiming about 3% of equities under Health Care industry.
Capitalization  Revenue  Valuation  Total debt  Workforce

Cabaletta Bio Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Cabaletta Bio's current stock value. Our valuation model uses many indicators to compare Cabaletta Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cabaletta Bio competition to find correlations between indicators driving Cabaletta Bio's intrinsic value. More Info.
Cabaletta Bio is rated fourth in price to earning category among related companies. It is rated below average in price to book category among related companies . The current year's Price To Book Ratio is expected to grow to 4.13. Comparative valuation analysis is a catch-all model that can be used if you cannot value Cabaletta Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cabaletta Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cabaletta Bio's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cabaletta Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cabaletta Bio and how it compares across the competition.

About Cabaletta Bio Valuation

The stock valuation mechanism determines the current worth of Cabaletta Bio on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Cabaletta Bio. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cabaletta Bio based exclusively on its fundamental and basic technical indicators. By analyzing Cabaletta Bio's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cabaletta Bio's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cabaletta Bio. We calculate exposure to Cabaletta Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cabaletta Bio's related companies.
Last ReportedProjected for Next Year
Gross Profit-1.4 M-1.5 M
Pretax Profit Margin 0.00  0.00 
Operating Profit Margin 0.00  0.00 
Net Profit Margin 0.00  0.00 
Gross Profit Margin 0.00  0.00 

8 Steps to conduct Cabaletta Bio's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cabaletta Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cabaletta Bio's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Cabaletta Bio's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Cabaletta Bio's revenue streams: Identify Cabaletta Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Cabaletta Bio's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Cabaletta Bio's growth potential: Evaluate Cabaletta Bio's management, business model, and growth potential.
  • Determine Cabaletta Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cabaletta Bio's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Cabaletta Bio Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Cabaletta Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding40.9 M

Cabaletta Bio Current Valuation Indicators

Valuation refers to the process of determining the present value of Cabaletta Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cabaletta we look at many different elements of the entity such as Cabaletta's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Cabaletta Bio's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cabaletta Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cabaletta Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cabaletta Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cabaletta Bio's worth.
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Cabaletta Stock analysis

When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Cabaletta Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.65)
Return On Assets
(0.25)
Return On Equity
(0.40)
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.